Johnson & Johnson

NYSE:JNJ   3:59:59 PM EDT
137.16
-0.03 (-0.02%)
5:00:36 PM EDT: $137.10 -0.06 (-0.04%)
Earnings Announcements

Janssen Says FDA Approved SIMPONI ARIA For Patients 2 Yrs Of Age & Older For Treatment Of Active PJIA

Published: 09/30/2020 16:53 GMT
Johnson & Johnson (JNJ) - Janssen - FDA Approved Simponi Aria for Patients 2 Yrs of Age & Older for Treatment of Active Pjia & Extended Psa Indication for Same Patient Population.
Revenue is expected to be $21.7 Billion
Adjusted EPS is expected to be $1.84

Next Quarter Revenue Guidance is expected to be $21.65 Billion
Next Quarter EPS Guidance is expected to be $2.21

More details on our Analysts Page.